Does BENRALIZUMAB Cause Product dose omission issue? 713 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 713 reports of Product dose omission issue have been filed in association with BENRALIZUMAB (FASENRA). This represents 4.5% of all adverse event reports for BENRALIZUMAB.
713
Reports of Product dose omission issue with BENRALIZUMAB
4.5%
of all BENRALIZUMAB reports
12
Deaths
169
Hospitalizations
How Dangerous Is Product dose omission issue From BENRALIZUMAB?
Of the 713 reports, 12 (1.7%) resulted in death, 169 (23.7%) required hospitalization, and 12 (1.7%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENRALIZUMAB. However, 713 reports have been filed with the FAERS database.
What Other Side Effects Does BENRALIZUMAB Cause?
Asthma (2,457)
Dyspnoea (1,604)
Death (1,336)
Drug ineffective (1,266)
Cough (793)
Headache (788)
Pneumonia (710)
Wheezing (619)
Malaise (514)
Fatigue (495)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which BENRALIZUMAB Alternatives Have Lower Product dose omission issue Risk?
BENRALIZUMAB vs BENSERAZIDE
BENRALIZUMAB vs BENSERAZIDE\LEVODOPA
BENRALIZUMAB vs BENZALKONIUM
BENRALIZUMAB vs BENZOCAINE
BENRALIZUMAB vs BENZODIAZEPINE